CELANESE CORP (CE) Fundamental Analysis & Valuation

NYSE:CE • US1508701034

Current stock price

64.73 USD
-0.37 (-0.57%)
At close:
64.73 USD
0 (0%)
After Hours:

This CE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CE Profitability Analysis

1.1 Basic Checks

  • CE had positive earnings in the past year.
  • In the past year CE had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CE reported negative net income in multiple years.
  • CE had a positive operating cash flow in each of the past 5 years.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • CE has a worse Return On Assets (-5.35%) than 70.73% of its industry peers.
  • CE has a worse Return On Equity (-28.65%) than 76.83% of its industry peers.
  • CE's Return On Invested Capital of 3.36% is in line compared to the rest of the industry. CE outperforms 48.78% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CE is below the industry average of 6.49%.
Industry RankSector Rank
ROA -5.35%
ROE -28.65%
ROIC 3.36%
ROA(3y)-1.61%
ROA(5y)3.64%
ROE(3y)-10.48%
ROE(5y)9.46%
ROIC(3y)3.89%
ROIC(5y)6.43%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • CE has a Operating Margin (8.06%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of CE has declined.
  • Looking at the Gross Margin, with a value of 20.48%, CE is doing worse than 63.41% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 8.06%
PM (TTM) N/A
GM 20.48%
OM growth 3Y-17.56%
OM growth 5Y-8.76%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.97%
GM growth 5Y-2.2%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CE Health Analysis

2.1 Basic Checks

  • CE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CE has more shares outstanding
  • Compared to 5 years ago, CE has less shares outstanding
  • CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • CE has an Altman-Z score of 1.55. This is a bad value and indicates that CE is not financially healthy and even has some risk of bankruptcy.
  • CE has a worse Altman-Z score (1.55) than 64.63% of its industry peers.
  • The Debt to FCF ratio of CE is 15.69, which is on the high side as it means it would take CE, 15.69 years of fcf income to pay off all of its debts.
  • CE has a Debt to FCF ratio (15.69) which is in line with its industry peers.
  • A Debt/Equity ratio of 2.84 is on the high side and indicates that CE has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.84, CE is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 15.69
Altman-Z 1.55
ROIC/WACC0.4
WACC8.47%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that CE should not have too much problems paying its short term obligations.
  • CE has a Current ratio of 1.55. This is in the lower half of the industry: CE underperforms 67.07% of its industry peers.
  • CE has a Quick Ratio of 1.55. This is a bad value and indicates that CE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CE (0.94) is worse than 65.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.94
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CE Growth Analysis

3.1 Past

  • The earnings per share for CE have decreased strongly by -51.86% in the last year.
  • Measured over the past years, CE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.03% on average per year.
  • The Revenue has decreased by -7.16% in the past year.
  • The Revenue has been growing by 11.03% on average over the past years. This is quite good.
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.41% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CE will show a small growth in Revenue. The Revenue will grow by 2.05% on average per year.
EPS Next Y28.63%
EPS Next 2Y27.34%
EPS Next 3Y25.55%
EPS Next 5Y24.41%
Revenue Next Year-1.29%
Revenue Next 2Y0.97%
Revenue Next 3Y2.01%
Revenue Next 5Y2.05%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

6

4. CE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.10 indicates a correct valuation of CE.
  • Based on the Price/Earnings ratio, CE is valued a bit cheaper than 70.73% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CE to the average of the S&P500 Index (27.38), we can say CE is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 12.52, which indicates a correct valuation of CE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CE indicates a somewhat cheap valuation: CE is cheaper than 79.27% of the companies listed in the same industry.
  • CE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.20.
Industry RankSector Rank
PE 16.1
Fwd PE 12.52
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CE's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, CE is valued cheaply inside the industry as 93.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.02
EV/EBITDA 11.92
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CE's earnings are expected to grow with 25.55% in the coming years.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y27.34%
EPS Next 3Y25.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CE Dividend Analysis

5.1 Amount

  • CE has a yearly dividend return of 0.19%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.04, CE is paying slightly less dividend.
  • With a Dividend Yield of 0.19, CE pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

  • The dividend of CE decreases each year by -45.65%.
  • CE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-45.65%
Div Incr Years0
Div Non Decr Years0
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
DP-1.12%
EPS Next 2Y27.34%
EPS Next 3Y25.55%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

CE Fundamentals: All Metrics, Ratios and Statistics

CELANESE CORP

NYSE:CE (4/15/2026, 8:04:00 PM)

After market: 64.73 0 (0%)

64.73

-0.37 (-0.57%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners101.54%
Inst Owner Change-0.01%
Ins Owners0.22%
Ins Owner Change6.63%
Market Cap7.24B
Revenue(TTM)9.54B
Net Income(TTM)-1.16B
Analysts77.69
Price Target67.74 (4.65%)
Short Float %6.75%
Short Ratio2.72
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.12
Dividend Growth(5Y)-45.65%
DP-1.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-24
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.98%
Min EPS beat(2)-28.6%
Max EPS beat(2)6.64%
EPS beat(4)2
Avg EPS beat(4)5.58%
Min EPS beat(4)-28.6%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)1.68%
EPS beat(12)6
Avg EPS beat(12)1.16%
EPS beat(16)8
Avg EPS beat(16)1.24%
Revenue beat(2)0
Avg Revenue beat(2)-5.72%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-5.12%
Revenue beat(4)1
Avg Revenue beat(4)-2.48%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.65%
Revenue beat(12)1
Avg Revenue beat(12)-4.03%
Revenue beat(16)3
Avg Revenue beat(16)-2.74%
PT rev (1m)6.27%
PT rev (3m)25.84%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)-14.36%
EPS NY rev (1m)7.19%
EPS NY rev (3m)-9.06%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)-3.08%
Revenue NY rev (1m)1.14%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE 16.1
Fwd PE 12.52
P/S 0.76
P/FCF 9.02
P/OCF 6.32
P/B 1.79
P/tB N/A
EV/EBITDA 11.92
EPS(TTM)4.02
EY6.21%
EPS(NY)5.17
Fwd EY7.99%
FCF(TTM)7.17
FCFY11.08%
OCF(TTM)10.24
OCFY15.82%
SpS85.28
BVpS36.18
TBVpS-29.54
PEG (NY)0.56
PEG (5Y)N/A
Graham Number57.2037 (-11.63%)
Profitability
Industry RankSector Rank
ROA -5.35%
ROE -28.65%
ROCE 4.27%
ROIC 3.36%
ROICexc 3.61%
ROICexgc 6.41%
OM 8.06%
PM (TTM) N/A
GM 20.48%
FCFM 8.41%
ROA(3y)-1.61%
ROA(5y)3.64%
ROE(3y)-10.48%
ROE(5y)9.46%
ROIC(3y)3.89%
ROIC(5y)6.43%
ROICexc(3y)4.16%
ROICexc(5y)6.85%
ROICexgc(3y)8.18%
ROICexgc(5y)11.39%
ROCE(3y)4.97%
ROCE(5y)8.32%
ROICexgc growth 3Y-15.78%
ROICexgc growth 5Y-7.47%
ROICexc growth 3Y-10.97%
ROICexc growth 5Y-13.79%
OM growth 3Y-17.56%
OM growth 5Y-8.76%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.97%
GM growth 5Y-2.2%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.84
Debt/FCF 15.69
Debt/EBITDA 7.39
Cap/Depr 43.64%
Cap/Sales 3.59%
Interest Coverage 1.15
Cash Conversion 73.7%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.94
Altman-Z 1.55
F-Score4
WACC8.47%
ROIC/WACC0.4
Cap/Depr(3y)57.78%
Cap/Depr(5y)82.1%
Cap/Sales(3y)4.34%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
EPS Next Y28.63%
EPS Next 2Y27.34%
EPS Next 3Y25.55%
EPS Next 5Y24.41%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%
Revenue Next Year-1.29%
Revenue Next 2Y0.97%
Revenue Next 3Y2.01%
Revenue Next 5Y2.05%
EBIT growth 1Y-25.84%
EBIT growth 3Y-17.93%
EBIT growth 5Y1.31%
EBIT Next Year77.5%
EBIT Next 3Y26.23%
EBIT Next 5Y21.91%
FCF growth 1Y51.22%
FCF growth 3Y-14.31%
FCF growth 5Y-3.89%
OCF growth 1Y18.63%
OCF growth 3Y-14.27%
OCF growth 5Y-3.12%

CELANESE CORP / CE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


Can you provide the valuation status for CELANESE CORP?

ChartMill assigns a valuation rating of 6 / 10 to CELANESE CORP (CE). This can be considered as Fairly Valued.


How profitable is CELANESE CORP (CE) stock?

CELANESE CORP (CE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CELANESE CORP (CE) stock?

The Price/Earnings (PE) ratio for CELANESE CORP (CE) is 16.1 and the Price/Book (PB) ratio is 1.79.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 1 / 10.